1. Home
  2. PULM vs PPSI Comparison

PULM vs PPSI Comparison

Compare PULM & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • PPSI
  • Stock Information
  • Founded
  • PULM 2003
  • PPSI 2008
  • Country
  • PULM United States
  • PPSI United States
  • Employees
  • PULM N/A
  • PPSI N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • PPSI Electrical Products
  • Sector
  • PULM Health Care
  • PPSI Industrials
  • Exchange
  • PULM Nasdaq
  • PPSI Nasdaq
  • Market Cap
  • PULM 33.2M
  • PPSI 30.0M
  • IPO Year
  • PULM N/A
  • PPSI N/A
  • Fundamental
  • Price
  • PULM $6.50
  • PPSI $2.71
  • Analyst Decision
  • PULM
  • PPSI Strong Buy
  • Analyst Count
  • PULM 0
  • PPSI 1
  • Target Price
  • PULM N/A
  • PPSI $12.00
  • AVG Volume (30 Days)
  • PULM 60.7K
  • PPSI 37.9K
  • Earning Date
  • PULM 08-12-2025
  • PPSI 05-15-2025
  • Dividend Yield
  • PULM N/A
  • PPSI 54.74%
  • EPS Growth
  • PULM N/A
  • PPSI N/A
  • EPS
  • PULM N/A
  • PPSI 2.84
  • Revenue
  • PULM $1,921,000.00
  • PPSI $26,304,000.00
  • Revenue This Year
  • PULM N/A
  • PPSI $24.01
  • Revenue Next Year
  • PULM $134.88
  • PPSI $19.25
  • P/E Ratio
  • PULM N/A
  • PPSI $0.96
  • Revenue Growth
  • PULM N/A
  • PPSI 439.46
  • 52 Week Low
  • PULM $1.78
  • PPSI $2.25
  • 52 Week High
  • PULM $10.40
  • PPSI $7.00
  • Technical
  • Relative Strength Index (RSI)
  • PULM 39.79
  • PPSI 50.31
  • Support Level
  • PULM $6.26
  • PPSI $2.65
  • Resistance Level
  • PULM $6.96
  • PPSI $2.76
  • Average True Range (ATR)
  • PULM 0.87
  • PPSI 0.10
  • MACD
  • PULM -0.12
  • PPSI 0.00
  • Stochastic Oscillator
  • PULM 40.16
  • PPSI 61.54

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

Share on Social Networks: